mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.094 |
0.004 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.088 |
0.004 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.005 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.005 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.005 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.005 |